This guideline provides updated, evidence-based recommendations for the use and monitoring of heparin, including UFH, LMWHs, and fondaparinux, for healthcare professionals in the UK.
Answers are grounded in this paper and cite their sources.
Supports LMWH preference over UFH in UK practice; extends evidence synthesis into updated monitoring guidance.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Baglin et al. (2006) conducted a review in Thrombosis and anticoagulant therapy. Heparin (Unfractionated and Low-Molecular-Weight) was evaluated. The British Committee for Standards in Haematology provides updated evidence-based guidelines on the clinical use and monitoring of unfractionated and low-molecular-weight heparins.
Synapse has enriched 10 related papers. Consider them for comparative context: